IRIS
TERRANOVA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.722
NA - Nord America 935
EU - Europa 412
SA - Sud America 64
AF - Africa 10
OC - Oceania 7
Totale 7.150
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.955
US - Stati Uniti d'America 879
CN - Cina 378
HK - Hong Kong 306
IT - Italia 117
GB - Regno Unito 110
DE - Germania 67
BR - Brasile 42
CA - Canada 39
NL - Olanda 20
VN - Vietnam 20
CZ - Repubblica Ceca 18
IN - India 18
FR - Francia 13
JP - Giappone 13
MX - Messico 13
EE - Estonia 9
FI - Finlandia 9
TR - Turchia 9
AR - Argentina 8
ES - Italia 8
SE - Svezia 7
ZA - Sudafrica 7
AU - Australia 6
CL - Cile 6
PL - Polonia 6
AT - Austria 4
TW - Taiwan 4
BD - Bangladesh 3
EC - Ecuador 3
KR - Corea 3
NO - Norvegia 3
RS - Serbia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CH - Svizzera 2
HR - Croazia 2
ID - Indonesia 2
JM - Giamaica 2
LT - Lituania 2
MK - Macedonia 2
PE - Perù 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
GR - Grecia 1
IE - Irlanda 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.150
Salva come PNG Salva come JPEG
Città #
Hong Kong 303
Singapore 216
Hefei 214
Ashburn 212
Boardman 116
London 86
Shanghai 68
Santa Clara 66
Rome 62
Beijing 59
Los Angeles 36
San Francisco 35
Munich 33
Dallas 24
Washington 21
Buffalo 20
Montreal 19
Brno 18
Council Bluffs 16
Toronto 16
Amsterdam 14
Seattle 13
Secaucus 12
São Paulo 12
Tokyo 12
Ho Chi Minh City 11
Brooklyn 10
Chicago 10
Pune 10
Grumo Nevano 9
Boston 8
New York 8
Paris 8
Johannesburg 7
Coral Springs 6
Warsaw 6
Mexico City 5
Naples 5
Phoenix 5
Stockholm 5
Temecula 5
Canberra 4
Catania 4
Helsinki 4
Taipei 4
The Dalles 4
Turku 4
Ankara 3
Charlotte 3
Cusano Milanino 3
Las Vegas 3
Louisville 3
Mysore 3
Newark 3
Seoul 3
Sonoma 3
Zhengzhou 3
Brusaporto 2
Buenos Aires 2
Buford 2
Calgary 2
Chennai 2
Cleveland 2
Columbia 2
Cuautitlán Izcalli 2
Edinburgh 2
Elk Grove Village 2
Faella 2
Guangzhou 2
Hanoi 2
Hanover 2
Hyderabad 2
Leeds 2
Lima 2
Linköping 2
Manchester 2
Novi Sad 2
Nuremberg 2
Oklahoma City 2
Oslo 2
Pittsburgh 2
Poplar 2
Rio de Janeiro 2
Riyadh 2
Salerno 2
Salvador 2
San Jose 2
Santiago 2
Shijiazhuang 2
Skopje 2
Tallinn 2
Wandsworth 2
Zagreb 2
Almaty 1
Araxá 1
Arlington 1
Atlanta 1
Auckland 1
Baghdad 1
Bamako 1
Totale 1.954
Salva come PNG Salva come JPEG
Nome #
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 208
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 208
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 206
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 203
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 202
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 201
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 199
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 198
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 197
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 191
Human embryo: what about relatedness? 190
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 190
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 184
Does HE4 have a role in the recurrence of ovarian cancer? 183
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 180
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 180
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 178
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 175
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 171
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 165
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 164
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 107
A critical review on HE4 performance in endometrial cancer: where are we now? 103
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 102
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 100
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 93
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 92
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 91
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 91
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 89
A new type of absorbable barbed suture for use in laparoscopic myomectomy 89
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 86
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 86
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 85
Assessing HPV vaccination perceptions with online social media in Italy 85
[The role of laparoscopy in ovarian carcinoma]. 84
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study 83
Chirurgia Benigna 83
Economic impact among family caregivers of patients with advanced ovarian cancer 82
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 77
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 76
The role of ovarian fossa evaluation in patients with ovarian endometriosis 36
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 35
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 33
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 33
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 33
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 32
Ovarian cancer relapse: From the latest scientific evidence to the best practice 30
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 29
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 28
Miomectomia laparoscopica: fattibilità e learning curve 28
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 27
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 27
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 27
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 27
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 26
Ten years of HPV vaccines: State of art and controversies 26
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 26
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 26
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 25
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 25
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 25
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 24
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 24
Laparoscopic myomectomy learning curve safety and feasibility. 24
Real-time infrared thermography for ureter detection during hysterectomy 24
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 23
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 23
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 23
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 23
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 22
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 22
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 22
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 22
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 22
Studio prospettico randomizzato comparativo tra due tecniche 22
The role of macroplastique implantation in the management of occult urinary stress incontinence 22
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 21
Hormone replacement therapy in cancer survivors: Utopia? 21
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 21
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 21
The Role of Novel Serum Biomarker HE4 in Endometrial Cancer 20
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 20
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 20
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 20
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 19
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 19
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 19
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 19
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 18
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 18
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 18
REM (RISK OF ENDOMETRIAL MALIGNANCY): A PROPOSAL FOR A NEW SCORING SYSTEM TO EVALUATE RISK OF ENDOMETRIAL MALIGNANCY 17
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 17
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 16
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis 16
The role of novel serum biomarker HE4 in endometrial cancer 16
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 16
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 16
Pre-Operative Staging:What Is the Cost-Effective Workup? 15
Totale 7.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.948 107 25 122 33 27 98 84 69 277 347 2.304 2.455
2025/2026571 316 174 81 0 0 0 0 0 0 0 0 0
Totale 7.199